Guidelines: The National Clinical Cancer Care Guidelines (Sweden): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{forproviders}} | {{forproviders}} | ||
{{forpolicymakers}} | |||
Go back to [[Sweden]] page | Go back to [[Sweden]] page | ||
'''Primary purpose:''' To ensure equal and high-quality care for all patients by providing evidence-based recommendations on the investigation, treatment, nursing, rehabilitation, and follow-up of patients with cancer. | |||
'''Sponsor, manager or home institution:''' The National Clinical Cancer Care. | '''Sponsor, manager or home institution:''' The National Clinical Cancer Care. | ||
''' | '''Type of information:''' Recommendations, treatments, rehabilitation, palliative care, quality of life and follow-up of patients with various types of cancer. | ||
''' | '''Cancer areas of interest:''' [[hasCancerType::C00-D48: All neoplasms]]. | ||
'''Access to information:''' | '''Access to information:''' [https://kunskapsbanken.cancercentrum.se/vardprogram/ Click here to access]. | ||
Revision as of 18:56, 22 May 2024
Go back to Sweden page
Primary purpose: To ensure equal and high-quality care for all patients by providing evidence-based recommendations on the investigation, treatment, nursing, rehabilitation, and follow-up of patients with cancer.
Sponsor, manager or home institution: The National Clinical Cancer Care.
Type of information: Recommendations, treatments, rehabilitation, palliative care, quality of life and follow-up of patients with various types of cancer.
Cancer areas of interest: C00-D48: All neoplasms.
Access to information: Click here to access.
